Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315575 · ClinicalTrials.gov registry record
Memory Imaging of Normal Aging
A clinical trial, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 90
- Enrollment target
NCT00315575: Completed study, sponsored by National Institute on Aging (NIA).
NCT00315575 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00315575 has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to develop imaging techniques that can distinguish functional brain changes in people at high risk for dementia years prior to onset of clinical memory problems from those with normal changes of aging.
Interventions
- PROCEDURE BOLD and Perfusion brain MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-07 |
What the finished NCT00315575 record still lists
NCT00315575 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which BOLD and Perfusion brain MRI is the first listed.
NCT00315575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00315575 about?
NCT00315575 is a clinical study titled "Memory Imaging of Normal Aging". The purpose of this study is to develop imaging techniques that can distinguish functional brain changes in people at high risk for dementia years prior to onset of clinical memory problems from those with normal changes of aging.
What is the current status of trial NCT00315575?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2005-08. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00315575?
The interventions under investigation include: BOLD and Perfusion brain MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00315575?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia